Is this your podcast?
Sign up
to track ranks and reviews from Spotify, Apple Podcasts and more
Matt Pillar
Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.
Listen now
Ratings & Reviews
☆
☆
☆
☆
☆
4.6 stars from 89 ratings
great interview with bit.bio
☆
☆
☆
☆
☆
“Enjoyed your latest episode with bit.bio’s Mark Kotter!”
ladyscientistpodcast via Apple Podcasts ·
United States of America ·
02/13/24
Timely news & interesting guests
☆
☆
☆
☆
☆
“A great way to stay up to date with all that is happening in the biotech world. Lively discussions as the host Matt has unfiltered chats with top industry icons. Best podcast I’ve found in this field!”
Boddiingsytikgd via Apple Podcasts ·
United States of America ·
12/12/23
Great Show!
☆
☆
☆
☆
☆
“Very insightful! Matt's a great host, he knows what questions to ask his guests. A great podcast for latest trends in Biotech and Pharmacy industry!”Read full review »
Retchelle_Platforce via Apple Podcasts ·
Philippines ·
01/11/23
Recent Episodes
We love to hear from our listeners. Send us a message. Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly as it relates to using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that...
Published 09/23/24
Published 09/23/24
We love to hear from our listeners. Send us a message. SR One Capital Management CEO Simeon George, M.D. has a seemingly innate ability to pick winning biotech builders. Early on, he and his firm got behind CRISPR's Samarth Kulkarni, Ph.D., Arcellx' Rami Elghandour, and Nkarta's Paul Hastings,...
Published 09/16/24
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
